MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus
- PMID: 22252810
- PMCID: PMC3318397
- DOI: 10.1128/AAC.05325-11
MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus
Abstract
Mupirocin is a topical antibiotic used for the treatment of skin infections and the eradication of methicillin-resistant Staphylococcus aureus carriage. It inhibits bacterial protein synthesis by interfering with isoleucyl-tRNA synthetase activity. High-level mupirocin resistance (MIC of ≥ 512 μg/ml) is mediated by the expression of mupA (ileS2), which encodes an alternate isoleucyl-tRNA synthetase. In this study, we describe high-level mupirocin resistance mediated by a novel locus, mupB. The mupB gene (3,102 bp) shares 65.5% sequence identity with mupA but only 45.5% identity with ileS. The deduced MupB protein shares 58.1% identity (72.3% similarity) and 25.4% identity (41.8% similarity) with MupA and IleS, respectively. Despite this limited homology, MupB contains conserved motifs found in class I tRNA synthetases. Attempts to transfer high-level mupirocin resistance via conjugation or transformation (using plasmid extracts from an mupB-containing strain) were unsuccessful. However, by cloning the mupB gene into a shuttle vector, it was possible to transfer the resistance phenotype to susceptible S. aureus by electroporation, proving that mupB was responsible for the high-level mupirocin resistance. Further studies need to be done to determine the prevalence of mupB and to understand risk factors and outcomes associated with resistance mediated by this gene.
Figures


Similar articles
-
Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant Staphylococcus aureus with low-level mupirocin resistance.J Korean Med Sci. 2006 Oct;21(5):827-32. doi: 10.3346/jkms.2006.21.5.827. J Korean Med Sci. 2006. PMID: 17043414 Free PMC article.
-
Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA.J Antimicrob Chemother. 2013 Aug;68(8):1714-7. doi: 10.1093/jac/dkt085. Epub 2013 Mar 27. J Antimicrob Chemother. 2013. PMID: 23535880
-
High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases.Antimicrob Agents Chemother. 1993 Jan;37(1):32-8. doi: 10.1128/AAC.37.1.32. Antimicrob Agents Chemother. 1993. PMID: 8431015 Free PMC article.
-
Clinical relevance of mupirocin resistance in Staphylococcus aureus.J Hosp Infect. 2013 Dec;85(4):249-56. doi: 10.1016/j.jhin.2013.09.006. Epub 2013 Sep 21. J Hosp Infect. 2013. PMID: 24144552 Review.
-
Mupirocin resistance.Clin Infect Dis. 2009 Sep 15;49(6):935-41. doi: 10.1086/605495. Clin Infect Dis. 2009. PMID: 19673644 Review.
Cited by
-
Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance.BMC Microbiol. 2020 Jun 29;20(1):183. doi: 10.1186/s12866-020-01862-z. BMC Microbiol. 2020. PMID: 32600253 Free PMC article.
-
DNA microarray analysis of Staphylococcus aureus from Nigeria and South Africa.PLoS One. 2021 Jul 20;16(7):e0237124. doi: 10.1371/journal.pone.0237124. eCollection 2021. PLoS One. 2021. PMID: 34283846 Free PMC article.
-
Prevalence of qacA/B Genes and Mupirocin Resistance Among Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates in the Setting of Chlorhexidine Bathing Without Mupirocin.Infect Control Hosp Epidemiol. 2016 May;37(5):590-7. doi: 10.1017/ice.2016.1. Epub 2016 Feb 2. Infect Control Hosp Epidemiol. 2016. PMID: 26828094 Free PMC article.
-
Mechanisms of Bacterial Resistance to Antimicrobial Agents.Microbiol Spectr. 2018 Jan;6(1):10.1128/microbiolspec.arba-0019-2017. doi: 10.1128/microbiolspec.ARBA-0019-2017. Microbiol Spectr. 2018. PMID: 29327680 Free PMC article.
-
Epistasis analysis uncovers hidden antibiotic resistance-associated fitness costs hampering the evolution of MRSA.Genome Biol. 2018 Jul 18;19(1):94. doi: 10.1186/s13059-018-1469-2. Genome Biol. 2018. PMID: 30021593 Free PMC article.
References
-
- Clinical and Laboratory Standards Institute 2011. Performance standards for antimicrobial susceptibility testing. 21st informational supplement. M100-S21. CLSI, Wayne, PA
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical